Johnson & Johnson Near Deal For Pharmacyclics: FT

MarketWatch Pulse

Johnson & Johnson is near a deal for drugmaker Pharmacyclics Inc. , the Financial Times reported Wednesday on its web site. The parties are expected to reach a deal in the next few days, although talks could still fall apart, the newspaper said, citing people familiar with the matter. Shares of Johnson & Johnson rose 0.6% in after-hours trading Wednesday, while shares of Pharmacyclics rose 2.4%.

Copyright © 2015 MarketWatch, Inc.

Continue Reading Below